Paradoxical interactions between modifiers and elastase-2

FEBS Journal

Volumn 277, Issue 11, 2010, Pages 2486-2495

  Schenker, Patricia ^a   Baici, Antonio ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Activation; Electrostatic interactions; Glycosaminoglycans; Inhibition; Multiple interactions

Indexed keywords

ALPHA 1 PEPTIDASE INHIBITOR; ELASTASE; ELASTASE II; GLYCOSAMINOGLYCAN; PROTEIN INHIBITOR; PROTEOGLYCAN; UNCLASSIFIED DRUG;

ARTICLE; ENZYME INHIBITION; ENZYME KINETICS; EXTRACELLULAR MATRIX; HUMAN; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION;

ANIMALS; CHONDROITIN SULFATES; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; GLYCOSAMINOGLYCANS; HUMANS; KINETICS; MODELS, MOLECULAR; NEUTROPHILS; POLYSACCHARIDES; PROTEINS; SERINE ENDOPEPTIDASES; SULFATES;

EID: 77952729445     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2010.07663.x     Document Type: Article

References (29)

1. Bode W, Wei AZ, Huber R, Meyer E, Travis J Neumann S (1986) X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor. EMBO J 5, 2453 2458.
2. Kostoulas G, Hörler D, Naggi A, Casu B Baici A (1997) Electrostatic interactions between human leukocyte elastase and sulfated glycosaminoglycans: physiological implications. Biol Chem 378, 1481 1489.
3. Korkmaz B, Moreau T Gauthier F (2008) Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions. Biochimie 90, 227 242.
4. Baici A Bradamante P (1984) Interaction between human leukocyte elastase and chondroitin sulfate. Chem Biol Interact 51, 1 11.
5. Früh H, Kostoulas G, Michel BA Baici A (1996) Human myeloblastin (leukocyte proteinase 3): reactions with substrates, inactivators and activators in comparison with leukocyte elastase. Biol Chem 377, 579 586.
6. Marossy K (1981) Interaction of the chymotrypsin-and elastase-like enzymes of the human granulocyte with glycosaminoglycans. Biochim Biophys Acta 659, 351 361.
7. Walsh RL, Dillon TJ, Scicchitano R McLennan G (1991) Heparin and heparan sulphate are inhibitors of human leucocyte elastase. Clin Sci 81, 341 346.
8. Baici A, Diczházi C, Neszmélyi A, Móczár E Hornebeck W (1993) Inhibition of the human leukocyte endopeptidases elastase and cathepsin G and of porcine pancreatic elastase by N-oleoyl derivatives of heparin. Biochem Pharmacol 46, 1545 1549.
9. Baici A, Salgam P, Fehr K Böni A (1980) Inhibition of human elastase from polymorphonuclear leucocytes by a glycosaminoglycan polysulfate (Arteparon). Biochem Pharmacol 29, 1723 1727.
10. Steinmeyer J Kalbhen DA (1991) Influence of some natural and semisynthetic agents on elastase and cathepsin G from polymorphonuclear granulocytes. Arzneimittelforschung 41, 77 80.
11. Schenker P Baici A (2009) Simultaneous interaction of enzymes with two modifiers: reappraisal of kinetic models and new paradigms. J Theor Biol 261, 318 329.
12. Baici A (1981) The specific velocity plot. A graphical method for determining inhibition parameters for both linear and hyperbolic enzyme inhibitors. Eur J Biochem 119, 9 14.
13. Casu B, Petitou M, Provasoli M Sina P (1988) Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans. Trends Biochem Sci 13, 221 225.
14. Navia MA, McKeever BM, Springer JP, Lin TY, Williams HR, Fluder EM, Dorn CP Hoogsteen K (1989) Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-Å resolution. Proc Natl Acad Sci USA 86, 7 11.
15. Novinec M, Grass RN, Stark WJ, Turk V, Baici A Lenarčič B (2007) Interaction between human cathepsins K, L and S and elastins: mechanism of elastinolysis and inhibition by macromolecular inhibitors. J Biol Chem 282, 7893 7902.
16. Roughley PJ Barrett AJ (1977) The degradation of cartilage proteoglycans by tissue proteinases. Proteoglycan structure and its susceptibility to proteolysis. Biochem J 167, 629 637.
17. Keleti T (1967) The liberator. J Theor Biol 16, 337 355.
18. Baici A Seemüller U (1984) Kinetics of the inhibition of human leucocyte elastase by eglin from the leech Hirudo medicinalis. Biochem J 218, 829 833.
19. 1- antitrypsin inhibition mechanism. J Biol Chem 277, 11629 11635.
20. Tsuboi S, Nakabayashi K, Matsumoto Y, Teno N, Tsuda Y, Okada Y, Nagamatsu Y Yamamoto J (1990) Amino acids and peptides. XXVIII. Synthesis of peptide fragments related to eglin c and studies on the relationship between their structure and effects on human leukocyte elastase, cathepsin G and α-chymotrypsin. Chem Pharm Bull (Tokyo) 38, 2369 2376.
21. Belorgey D Bieth JG (1995) DNA binds neutrophil elastase and mucus proteinase inhibitor and impairs their functional activity. FEBS Lett 361, 265 268.
22. 1- proteinase inhibitor. Biochemistry 37, 16416 16422.
23. 1-proteinase inhibitor. J Biol Chem 266, 15356 15362.
24. Cadène M, Boudier C, Daney-de Marcillac G Bieth JG (1995) Influence of low molecular mass heparin on the kinetics of neutrophil elastase inhibition by mucus proteinase inhibitor. J Biol Chem 270, 13204 13209.
25. Baici A (1998) Inhibition of extracellular matrix-degrading endopeptidases: problems, comments, and hypotheses. Biol Chem 379, 1007 1018.
26. Schechter I Berger A (1967) On the size of the active sites in proteases. I. Papain. Biochem Biophys Res Commun 27, 157 162.
27. Baici A Lang A (1990) Cathepsin B secretion by rabbit articular chondrocytes: modulation by cycloheximide and glycosaminoglycans. Cell Tissue Res 259, 567 573.
28. Bertini S, Bisio A, Torri G, Bensi D Terbojevich M (2005) Molecular weight determination of heparin and dermatan sulfate by size exclusion chromatography with a triple detector array. Biomacromolecules 6, 168 173.
29. Seemüller U, Meier M, Ohlsson K, Müller HP Fritz H (1977) Isolation and characterisation of a low molecular weight inhibitor (of chymotrypsin and human granulocyte elastase and cathepsin G) from leeches. Hoppe-Seylers Z Physiol Chem 358, 1105 1117.